You are here: Industry Insights > AI

News List

I-Mab Expands Emerging Portfolio of Next Generation Novel Oncology Therapeutics Through Cutting-Edge mRNA and AI Technology Platforms prnasia
July 12, 2021
I-Mab announced the signing of two new collaborations with emerging biotech companies in China to strengthen its next-generation innovation pipeline.
Kuano raises £1m to further develop AI drug discovery platform pharmatimes
July 09, 2021
London-headquartered artificial intelligence company Kuano has raised £1m in seed funding to accelerate the development of its platform, focused on transforming the discovery of therapeutics targeting enzyme inhibition.
Exscientia receives $1.5m Gates Foundation grant for AI-designed Covid-19 drugs pharmaceutical-technology
July 09, 2021
UK-based artificial intelligence (AI) drug discovery company Exscientia has received a $1.5m grant from the Bill & Melinda Gates Foundation and Gates Philanthropy Partners to accelerate the development of a new class of Covid-19 drugs.
Standigm Secures $10 M From Pavilion Capital to Accelerate Its Global Competitiveness firstwordpharma
July 07, 2021
Standigm Inc. ("Standigm"), the leading workflow artificial intelligence (AI) drug discovery company, announced today that they have secured a $10 million investment from Pavilion Capital, a Singapore-based investment institution.
Exscientia signs $1.2bn AI drug discovery deal with BMS pharmaceutical-technology
May 21, 2021
Bristol-Myers Squibb (BMS) and Exscientia have signed a partnership agreement to leverage artificial intelligence (AI) for the discovery of small molecule drug candidates in various therapeutic areas, including oncology and immunology.
Alzheimer’s drug designed using Exscientia’s AI technology enters clinic pharmatimes
May 17, 2021
An Alzheimer’s disease drug candidate designed using Exscientia’s artificial intelligence (AI) technology has entered Phase I clinical testing, the company announced May 13.
Artificial Intelligence helps IVF patients avoid invasive embryo genetic testing Presagen
May 17, 2021
Presagen has made a significant breakthrough in using artificial intelligence to non-invasively help embryologists rank and select genetically healthy embryos in IVF.
First AI designed Alzheimer’s drug to enter clinical trials europeanpharmaceuticalreview
May 14, 2021
The trial of DSP-0038, an Alzheimer’s disease psychosis drug designed using artificial intelligence, will assess its ability to improve the behavioural and psychological symptoms of dementia.
Abbott’s AI-powered coronary imaging platform deployed in the UK pharmatimes
May 14, 2021
Abbott UK’s artificial intelligence- (AI) powered coronary imaging platform has been offered to the first heart attack patients in the country at the Royal Free Hospital in London.
Artificial intelligence model predicts which key of the immune system opens the locks of coronavirus worldpharmanews
April 26, 2021
The human immune defense is based on the ability of white blood cells to accurately identify disease-causing pathogens and to initiate a defense reaction against them.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 18 19 Next page